The debate about the possibility of legalization has usually been characterised by two positions: Some Medical practitioners and wellbeing industry experts warn versus trivializing cannabis. Neurologist Euphrosyne Gouzoulis-Mayfrank, incoming president of the German Modern society for Psychiatry, Psychotherapy and Psychosomatics (DGPPN), has mentio